Insights

Gathering insights about iCAD…

Similar companies to iCAD

iCAD Tech Stack

iCAD uses 8 technology products and services including Google Analytics, MySQL, Adobe Fonts, and more. Explore iCAD's tech stack below.

Google Analytics
Analytics
MySQL
Database
Adobe Fonts
Font Scripts
Microsoft
Miscellaneous
Amazon Web Services
Platform As A Service
Java
Programming Languages
Python
Programming Languages
Apache
Web Servers

Media & News

iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America
NASHUA, N.H. and TORONTO, March 05, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and RamSoft®, a global leader in cloud-based RIS/PACS radiology solutions for imaging centers and providers, today announced a new strategic commercial preferred distributor and integration partnership across the US and Canada. With over 750 sites and thousands of healthcare providers worldwide utilizing RamSoft's solutions, this collaboration brings iCAD's ProFound AI® Breast Health Suite directly into imaging centers, enhancing workflow efficiency, increasing diagnostic confidence, and improving patient care, beginning within the platforms they already use.
Mar 05, 2025 | www.globenewswire.com
Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025
NASHUA, N.H. and CHICAGO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and Koios Medical, a leader in AI-driven ultrasound cancer diagnosis, today announced a strategic reseller partnership to deliver a comprehensive, multi-modality AI suite for breast cancer detection. This collaboration integrates iCAD's ProFound AI® Breast Health Suite for mammography with Koios SmartUltrasound™, providing radiologists with an AI-powered pathway from screening to diagnosis.
Feb 26, 2025 | www.globenewswire.com
iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025
NASHUA, N.H., Feb. 19, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health solutions, today announced that five clinical presentations and abstracts highlighting the Company's advancements in breast cancer detection, risk evaluation, and breast arterial calcification (BAC) assessment have been accepted for presentation at the European Congress of Radiology (ECR) 2025, which will take place from February 26 to March 2, 2025, in Vienna, Austria.
Feb 19, 2025 | www.globenewswire.com
iCAD Pre-Announces Estimated Q4 2024 Revenue
iCAD to Participate in the BTIG at Snowbird: 12 th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Jan 27, 2025 | www.globenewswire.com
Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions
-New FDA Consultant is the former Director of the Division of Imaging, Diagnostics, and Software Reliability at the U.S Food and Drug Administration- -New Biostatistical Consultant is the former Deputy Director of the Biostatistics and Data Management Center of the American College of Radiology Imaging Network, an NIH-funded cooperative that conducts clinical trials to evaluate the use of diagnostic imaging and image-guided treatments for cancer, has decades of successful experience in design and analysis of clinical studies of medical imaging devices supporting U.S. Food and Drug Administration approval applications - -New Regulatory Consultant is the former VP of Regulatory Affairs, Clinical Affairs, and Quality Assurance for iCAD (NASDAQ: ICAD), a medical device manufacturer that offers computer-aided detection solutions for cancers including breast, and technology platforms including hardware and software for radiation therapy treatment- Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - January 15, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing imaging-based products utilizing innovative and emerging technologies for the more accurate screening, diagnoses, and treatment of breast cancers, is pleased to announce that Dr. Kyle J. Myers, Dr. Alicia Toledano, and Mr.
Jan 15, 2025 | www.newsfilecorp.com
SABCS 2024: New Research Assesses iCAD's Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations
Reveals Higher Prevalence of Breast Arterial Calcifications (BAC) in Breast Cancer Patients, Suggesting Potential Need for Cardiovascular Assessment Alongside Oncological Treatment Reveals Higher Prevalence of Breast Arterial Calcifications (BAC) in Breast Cancer Patients, Suggesting Potential Need for Cardiovascular Assessment Alongside Oncological Treatment
Dec 11, 2024 | www.globenewswire.com
CORRECTION – iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024
ProFound Health, a Virtual Care Partnership with Cascaid Health, to Democratize Access to AI-Powered Mammography for All Patients – Launching Q1 2025 ProFound Health, a Virtual Care Partnership with Cascaid Health, to Democratize Access to AI-Powered Mammography for All Patients – Launching Q1 2025
Dec 04, 2024 | www.globenewswire.com

iCAD's Email Address Formats

iCAD uses at least 1 format(s):

iCAD Email Formats	Example	Percentage
FLast@icadmed.com	JDoe@icadmed.com	89%
Last@icadmed.com	Doe@icadmed.com	6%
First.Last@icadmed.com	John.Doe@icadmed.com	4%
First_Last@icadmed.com	John_Doe@icadmed.com	1%

Frequently Asked Questions

Where is iCAD's headquarters located?

iCAD's main headquarters is located at 2 Townsend W Suite 6 Nashua, New Hampshire 03063 US. The company has employees across 6 continents, including North AmericaAsiaSouth America.

What is iCAD's phone number?

You can contact iCAD's main corporate office by phone at

+1-603-882-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is iCAD's stock symbol?

iCAD is a publicly traded company; the company's stock symbol is ICAD.

What is iCAD's official website and social media links?

iCAD's official website is icadmed.com and has social profiles on LinkedIn.

How much revenue does iCAD generate?

As of January 2025, iCAD's annual revenue reached $35M.

What is iCAD's NAICS code?

iCAD's NAICS code is 62 - Health Care and Social Assistance.

How many employees does iCAD have currently?

As of January 2025, iCAD has approximately 327 employees across 6 continents, including North AmericaAsiaSouth America. Key team members include CEO: G. S.Chief People Officer: B. T.Chief Operating Officer: M. S.. Explore iCAD's employee directory with LeadIQ.

What industry does iCAD belong to?

iCAD operates in the Hospitals and Health Care industry.

What technology does iCAD use?

iCAD's tech stack includes Google AnalyticsMySQLAdobe FontsMicrosoftAmazon Web ServicesJavaPythonApache.

What is iCAD's email format?

iCAD's email format typically follows the pattern of . Find more iCAD email formats with LeadIQ.

How much funding has iCAD raised to date?

As of January 2025, iCAD has raised $22M in funding. The last funding round occurred on Mar 03, 2021 for $22M.

When was iCAD founded?

iCAD was founded in 1984.

iCAD

Hospitals and Health CareNew Hampshire, United States201-500 Employees

At iCAD, we believe that is possible to create a world where cancer can't hide.  Leveraging the power of artificial intellegence (AI), we empower healthcare providers to more accurately, reliably, and quickly detect disease and improve outcomes.
 
The ProFound Breast Health Suite offers a comprehensive portfolio of clinically proven AI technologies for breast cancer detection, automated breast density assessment, and short-term personalized risk evaluation providing certainty and peace of mind - Optimizing every patient’s opportunity to live better, longer lives!

To learn more, visit www.icadmed.com.

Company Overview

Headquarters: 2 Townsend W Suite 6 Nashua, New Hampshire 03063 US
Phone number: +1-603-882-****
Website: icadmed.com
Stock Symbol: ICAD
NAICS Code: 62 - Health Care and Social Assistance
Founded: 1984
Employees: 201-500

Media & News

Funding & Financials

$22M
iCAD has raised a total of $22M of funding over 4 rounds. Their latest funding round was raised on Mar 03, 2021 in the amount of $22M.
$10M$50M
iCAD's revenue is in the range of $10M$50M

Funding & Financials

$22M
iCAD has raised a total of $22M of funding over 4 rounds. Their latest funding round was raised on Mar 03, 2021 in the amount of $22M.
$10M$50M
iCAD's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to iCAD

Riverain Technologies

EPIC Systems

Subtle Medical

Median Technologies

Therapixel

GE HealthCare

Aidence

iCAD Tech Stack

Media & News

iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America

Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025

iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025

iCAD Pre-Announces Estimated Q4 2024 Revenue

Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions

SABCS 2024: New Research Assesses iCAD's Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations

CORRECTION – iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024

iCAD's Email Address Formats

Frequently Asked Questions

Where is iCAD's headquarters located?

What is iCAD's phone number?

What is iCAD's stock symbol?

What is iCAD's official website and social media links?

How much revenue does iCAD generate?

What is iCAD's NAICS code?

How many employees does iCAD have currently?

What industry does iCAD belong to?

What technology does iCAD use?

What is iCAD's email format?

How much funding has iCAD raised to date?

When was iCAD founded?

iCAD

Company Overview

Media & News

iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America

Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025

iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?